)
)
Xenetic Biosciences Investor Relations Material
Latest events
Status Update
Xenetic Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Xenetic Biosciences Inc
Access all reports
Xenetic Biosciences, Inc. is a biotechnology company focused on developing immune-oncology therapies and drug delivery technologies. The company specializes in advancing novel treatments for cancer, leveraging its proprietary DNase-based platform designed to improve the effectiveness of chemotherapy and immunotherapy. The company is headquartered in Framingham, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Xenetic Biosciences Inc
Corporate Presentation
Xenetic Biosciences Inc
Corporate Presentation
Xenetic Biosciences Inc
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
XBIO
Country
🇺🇸 United States